|
|
||||||||
1 Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University and 2 Department of Endoscopic Diagnostics and Therapeutics, Kyushu University Hospital, Fukuoka 812-8582, Japan
Epidermal growth factor
(EGF) has been shown to exert gastric hyperemic and gastroprotective
effects via capsaicin-sensitive afferent neurons, including the release
of calcitonin gene-related peptide (CGRP). We examined the protective
and vasodilatory effects of EGF on the gastric mucosa and its
interaction with sensory nerves, CGRP, and nitric oxide (NO) in
anesthetized rats. Intragastric EGF (10 or 30 µg) significantly
reduced gastric mucosal lesions induced by intragastric 60% ethanol
(50.6% by 10 µg EGF and 70.0% by 30 µg EGF). The protective
effect of EGF was significantly inhibited by pretreatment with
capsaicin desensitization, human CGRP1 antagonist
hCGRP-(8-37), or
N
-nitro-L-arginine methyl ester
(L-NAME). Intravital microscopy showed that topically
applied EGF (10-1,000 µg/ml) dilated the gastric mucosal
arterioles dose dependently and that this vasodilatory effect was
significantly inhibited by equivalent pretreatments. These findings
suggest that EGF plays a protective role against ethanol-induced
gastric mucosal injury, possibly by dilating the gastric mucosal
arterioles via capsaicin-sensitive afferent neurons involving CGRP and
NO mechanisms.
vasodilatation; sensory nerves; calcitonin gene-related peptide; nitric oxide
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |